Dumpster Fire Extraordinaire

Discussion in 'Procept BioRobotics' started by anonymous, May 25, 2021 at 8:11 PM.

  1. anonymous

    anonymous Guest

    Like all things, the truth falls somewhere in the middle. I am a rep. The tech is good, especially for Gen 1. Maybe commentators on here don't know the space. The BPH space has imperfect options for patients hence why $ floods to this space. Aquablation is great for glands over 60g. Not worth time to set up etc for smaller. For 100g and over, it will be the gold standard. Negatives are that most Drs and staff will always need reps in most markets forever imo. Lot of case chasing/coverage. The reputation of issues at Procept are true but turned a corner mid 2022. $ for capital and ASRs good to great. Compared to most other companies, both money is better and culture is not terrible. 2023 will be make it or break it time for company and technology. Mgmt is not the best, not very experiences, grasp in the dark a lot, wasted lots of time in 2022 and who knows if they figured it out. TBD
     

  2. anonymous

    anonymous Guest

    They will never figure it out with the current Mgmt. Agree there are imperfect options in BPH space but this technology is about as far from perfect as all of them. The equipment malfunctions, case delays and serious adverse events are much worse than the other imperfect options available. If it was my Dad, I’d steer him away from this technology.
     
  3. anonymous

    anonymous Guest

    This will never be the Gold Standard for BPH, regardless of gland size...
     
  4. anonymous

    anonymous Guest

    There’s 200 robots out already…fastest start in any robotics. Yes including intuitive.
     
  5. anonymous

    anonymous Guest

    Guessing the negatives are from x employees that jumped early. Most of the Salesforce have backgrounds from Intuitive, Mako, mazor etc. qualify that via LinkedIn. If this wasn’t the real deal top talent wouldn’t make a move to Procept.
     
  6. anonymous

    anonymous Guest

    Top talent? That’s funny.
     
  7. anonymous

    anonymous Guest

    A bit of a stretch there pal.
     
  8. anonymous

    anonymous Guest

    Top talent? Really? I know and have worked with many of the initial reps that were on board to launch your joke of a "robotic TURP". They were the Top Talent. And if they couldn't sell it - it's going to be a really long slog. Please own up to the fact that it's unnecessary tech in the world of BPH. The good urologists can do a great TURP in half the time it takes to set up the "procept system".
     
  9. anonymous

    anonymous Guest

    Can you do a 100+g turp and preserve sexual function? Gtfo. Why is the reimbursement double to that of a TURP? Oh I know. Only FDA pivotal trial against TURP which showed superior efficacy and durability.

    This is the future like it or not. 100 year old technology through a straw is over.
     
  10. anonymous

    anonymous Guest

    Get back to everyone when you've figured out how to stop the bleeding. The first patient ever done this way is *still bleeding*. CBI never ends.

    446 Maude reports can't be good.
     
  11. anonymous

    anonymous Guest

    Dude they did 150g prostates with zero cautery in a study. Can you imagine doing a TURP and only hitting cut? Or doing any modality with zero energy cautery for that matter. Not a fuckin chance.

    Better to figure that out at the starting gates which Procept did. There’s a hemostasis protocol now because of that study. Results are now undeniably superior to any resective procedure
     
  12. anonymous

    anonymous Guest

    I'd love to see that study. Please post the link here. Thank you.
     
  13. anonymous

    anonymous Guest

    If this is the case genius, then explain to me why some Payers
    A) limit the treatment to Prostate sizes less than 80g
    B) have an upper patient age limit for treatment and
    C) only allow “eligible” patients to have 1 Aquablation procedure in their lifetime?

    let’s not forget the good ole MAUDE database - let’s also not forget that the majority of “robots” in the Install Base are installed outside of the US. MAUDE is ONLY capturing the adverse events that are “self-reported” by Procept AND within the US! So these 400+ adverse events are likely barely scratching the surface.

    anyone wanna do the math on this?
     
  14. anonymous

    anonymous Guest

    how bad are you getting your ass kicked is the real question? What do you carry Rezum or urolift lol
     
  15. anonymous

    anonymous Guest

    water 2 study
     
  16. anonymous

    anonymous Guest

    This is spreading like wild fire now that it’s got coverage. When the hospital sees reimbursement of 2x on what they are currently doing its a slam dunk no brainer. Even United healthcare is on board now. Places are buying these even without surgeon champions because of it
     
  17. anonymous

    anonymous Guest

    I don't work in the urology world but lately I am seeing Procept at every hospital I visit in my line of work. I spoke to a urologist friend and he said aquablation is revolutionary and in 5 years will be the standard of care BPH. Hearing this, I picked up a few shares, seems cheap at current prices. Last time I did that it was a little company called Sofamor Danek which later became Medtronic. I made a shed load on that one. What I don't understand is why do so many come on here to dump on this company? Procept might be a bad place to work but it could be an amazing investment. I suggest bashers do some research and pick up some shares if swayed by what you learn. Then once invested, go out and tell everyone you know how great the technology is and, yes, how awesome the company is too! One is is for sure, you won't make any money bashing!
     
  18. anonymous

    anonymous Guest

    ARE YOU SERIOUS? You’re a joke.
     
  19. anonymous

    anonymous Guest

    Kyle Kelch is an ass hat!